How well is the clinical importance of study results reported? An assessment of randomized controlled trials
- PMID: 11706908
- PMCID: PMC81581
How well is the clinical importance of study results reported? An assessment of randomized controlled trials
Abstract
Background: The interpretation of the results of randomized controlled trials (RCTs) has traditionally emphasized statistical significance rather than clinical importance. Our aim was to assess the quality of reporting of factors related to clinical importance in a sample of published RCTs.
Methods: A random sample of 27 (of a total of 266) RCTs published in 5 major medical journals over a 1-year period were reviewed by 4 independent reviewers for factors considered important in the interpretation of the clinical importance of study results: identification of a clearly defined primary outcome, reporting of the expected difference between groups used in the calculation of sample size (the delta value) and whether it was based on the minimal clinically important difference of the intervention, the statistical significance of the results, presentation of pertinent confidence intervals, and the authors' interpretation of the clinical importance of the results.
Results: Twenty-two of 27 (81%) articles explicitly reported a single primary outcome. Of the 20 articles that included a sample size calculation, 18 (90%) reported a delta value. Two of the 18 (11%) articles explicitly stated that the delta value was chosen to reflect the minimal clinically important difference of the intervention. For the primary outcomes, confidence intervals surrounding the point estimates of the efficacy of the interventions were reported in 11 of 27 (41%) studies. The study results were interpreted from the perspective of clinical importance in 20 of 27 (74%) of the articles. Of these 20 reports, 5 (25%) provided justification for their clinical interpretation of the results.
Interpretation: Authors of RCTs published in major general medical and internal medicine journals do not consistently provide their own interpretation of the clinical importance of their results, and they often do not provide sufficient information to allow readers to make their own interpretation.
Comment in
-
Reporting the clinical importance of randomized controlled trials.CMAJ. 2002 Mar 19;166(6):711-2; author reply 712. CMAJ. 2002. PMID: 11944756 Free PMC article. No abstract available.
-
Reporting the clinical importance of randomized controlled trials.CMAJ. 2002 Mar 19;166(6):712; author reply 712. CMAJ. 2002. PMID: 11944757 Free PMC article. No abstract available.
References
-
- Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001;134(8):657-62. - PubMed
-
- Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology:a basic science for clinical medicine. 2nd ed. Boston: Little, Brown and Company; 1991.
-
- Greene WL, Concato J, Feinstein AR. Claims of equivalence in medical research: Are they supported by the evidence? Ann Intern Med 2000;132:715-22. - PubMed
-
- Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15. - PubMed
-
- Hart RG, Halperin JL, McBride R, Benavente O, Man-Son-Hing M, Kronmal RA. Aspirin for the primary prevention of stroke and other major vascular events. Arch Neurol 2000;57:326-32. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical